Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Ensuring Uniformity of Content in Creams – V 2.0

Posted on By

Creams: SOP for Ensuring Uniformity of Content in Creams – V 2.0

Standard Operating Procedure for Ensuring Uniformity of Content in Creams

Department Creams
SOP No. SOP/CRM/141/2025
Supersedes SOP/CRM/141/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for ensuring the uniformity of content in cream formulations. Uniformity of content is crucial for consistent product quality, ensuring that each batch of cream contains the correct proportions of active ingredients and excipients. This SOP ensures that the distribution of components in the cream is consistent across each batch.

2. Scope

This SOP applies to all cream formulations produced at the facility. It covers the processes involved in verifying and ensuring the uniformity of active ingredients, excipients, and other critical components in cream batches, both during production and after filling.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream formulation is mixed and processed uniformly during production. They are also responsible for providing representative samples for uniformity testing.
  • Quality Control (QC) Team: Responsible for conducting uniformity of content testing and ensuring that the test results meet the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of the uniformity of content tests to ensure compliance with internal specifications and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that uniformity of content testing is performed according to this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are uniformly mixed during production. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

See also  Creams: SOP for Cleaning Manufacturing Tanks for Creams - V 2.0

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for content uniformity testing is available, including a suitable laboratory balance for accurate measurements, and sampling tools for obtaining representative samples from the cream batch.
  2. Ensure that all necessary reagents and solvents are prepared for use in the analysis, including the correct concentration for any active ingredients or preservatives.
  3. Review the batch record to confirm the formulation details and the specified uniformity requirements for the active ingredients and excipients.

5.2 Sample Collection

  1. Collect representative samples from different parts of the batch, including the top, middle, and bottom sections of the cream container to ensure an accurate representation of the entire batch.
  2. Ensure that the samples are taken using proper aseptic techniques to prevent contamination and maintain uniformity.
  3. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.

5.3 Uniformity of Content Testing Procedure

  1. Weigh each sample using a calibrated laboratory balance to ensure the correct quantity is used for analysis.
  2. Analyze the active ingredient(s) in each sample using a validated method (e.g., HPLC, UV-Visible spectrophotometry) to quantify the concentration of the active ingredient and verify that it is within the specified limits.
  3. Perform testing for each sample in triplicate to ensure consistency and reliability of the results.
  4. Record the results of each test, including the measured concentration of the active ingredient(s) and any variations from the expected content, in the Uniformity of Content Testing Log (Annexure-1).
See also  Creams: SOP for Setting Parameters for Jar Filling Machines - V 2.0

5.4 Interpretation of Results

  1. Compare the results of the uniformity of content test with the established specifications for content uniformity. The content of the active ingredient(s) should fall within the acceptable range, which is typically within ±10% of the nominal content.
  2. If the test results show that the content is within the specified range, mark the test as “Pass” in the Uniformity of Content Testing Log (Annexure-1) and proceed with the next stage of production or release.
  3. If the test results show that the content is outside the acceptable range, mark the test as “Fail.” Investigate the cause of the failure, which may include inadequate mixing, incorrect formulation, or insufficient homogenization.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, test date, content uniformity results, and any corrective actions taken in the Uniformity of Content Testing Log (Annexure-1).
  2. If the uniformity of content test fails, initiate corrective actions such as adjusting the formulation, improving mixing techniques, or reprocessing the batch to ensure content uniformity. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all uniformity of content testing records are complete, accurate, and securely stored. This includes the Uniformity of Content Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.
See also  Creams: SOP for Semi-Solid Product Storage in Bulk Containers - V 2.0

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Uniformity of Content Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for Uniformity of Content Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Uniformity of Content Testing Log

Batch Number Sample ID Test Date Active Ingredient Content (%) Operator
12345 S-001 21/01/2026 98.5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Active ingredient content out of specification Reprocessed and re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Analytical Method Development: Residue on Ignition / Sulphated Ash Method Development – V 2.0
Next Post: Aerosol: SOP for Qualification of Compressed Air Systems for Aerosols – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version